LE HR (Letrozole 2.5 mg)
Pill with imprint LE HR is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Jiangsu Hengrui Pharmaceutical Co., Ltd..
Letrozole is used in the treatment of breast cancer; breast cancer, adjuvant; breast cancer, metastatic and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LE HR
Letrozole
- Imprint
- LE HR
- Strength
- 2.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 57884-2021
Related Images for "LE HR"
More about letrozole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 248 Reviews
- Drug class: aromatase inhibitors
Consumer resources
- Other brands
- Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.